News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com95d agoneutral
Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ...BioPharma Dive95d agoneutral
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchGuruFocus.com95d agoneutral
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV ...The Wall Street Journal96d agoneutral
Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift RevenueBarrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryInvestor's Business Daily96d agobearish
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-UpInvestor's Business Daily114d agoneutral
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.The Wall Street Journal137d agoneutral
New Drugs Are Replacing Chemo for Aggressive Breast Cancer